STATE OF WISCONSIN INVESTMENT BOARD

Position in DSGN — Design Therapeutics, Inc.

CIK 854157 MADISON, WI

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$857,333

+$333,697 QoQ

Shares Held

59,249

+20.4% QoQ

Ownership

0.095%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 136 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STATE OF WISCONSIN INVESTMENT BOARD holds $515,131,053 across 164 Biotechnology names. DSGN ranks #110 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,798	$67,454,940
2	REGN	Regeneron Pharmaceuticals, Inc.	55,287	$34,473,655
3	ALNY	Alnylam Pharmaceuticals, Inc.	70,171	$21,123,576
4	RVMD	Revolution Medicines, Inc.	83,892	$15,711,293
5	XENE	Xenon Pharmaceuticals Inc.	248,821	$15,018,835
6	MRNA	Moderna, Inc.	207,705	$14,545,581
7	INSM	INSMED Inc	118,057	$12,587,237
8	RPRX	Royalty Pharma plc	213,373	$11,963,824

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$857,333	59,249	+20.4%	Shares	Sole	2026-08-14
2026-03-31	$523,636	49,214	-2.8%	Shares	Sole	2026-05-15
2025-12-31	$475,162	50,657	+87.2%	Shares	Sole	2026-02-17
2025-09-30	$203,776	27,062	-5.6%	Shares	Sole	2025-11-14
2025-06-30	$96,590	28,662	+30.5%	Shares	Sole	2025-08-14
2025-03-31	$84,773	21,962	-73.9%	Shares	Sole	2025-05-15
2023-06-30	$529,200	84,000	+94.9%	Shares	Sole	2023-08-14
2023-03-31	$248,687	43,100	+21.1%	Shares	Sole	2023-05-15
2022-03-31	$574,940	35,600	+104.6%	Shares	Sole	2022-05-13
2021-12-31	$372,534	17,400	0.0%	Shares	Sole	2022-02-11
2021-09-30	$255,606	17,400	0.0%	Shares	Sole	2021-11-12
2021-06-30	$346,086	17,400	—	Shares	Sole	2021-08-12
No filing history on record for this holder in this stock.